New epilepsy drug tested for Long-Term safety in kids
NCT ID NCT06315322
First seen Jun 27, 2026 · Last updated Aug 14, 2026 · Updated 4 times
Summary
This study looks at the long-term safety of the drug brivaracetam in children and teenagers with childhood absence epilepsy or juvenile absence epilepsy. About 120 participants who have already taken the drug in earlier studies will continue treatment and be monitored for side effects. The goal is to see if the drug is safe to use over a long period to control seizures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDHOOD ABSENCE EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ep0224 20321
Tbilisi, Georgia
-
Ep0224 20322
Tbilisi, Georgia
-
Ep0224 20323
Tbilisi, Georgia
-
Ep0224 20324
Tbilisi, Georgia
-
Ep0224 40144
Abbiategrasso, Italy
-
Ep0224 40629
Roma, Italy
-
Ep0224 40763
Verona, Italy
-
Ep0224 40764
Pavia, Italy
-
Ep0224 40765
Messina, Italy
-
Ep0224 40766
Roma, Italy
-
Ep0224 40767
Bucharest, Romania
-
Ep0224 40768
Iași, Romania
-
Ep0224 40769
Bucharest, Romania
-
Ep0224 40770
Timișoara, Romania
-
Ep0224 40771
Bardejov, Slovakia
-
Ep0224 40772
Dubnica nad Váhom, Slovakia
-
Ep0224 50140
Birmingham, Alabama, 35233-2110, United States
-
Ep0224 50268
Miami, Florida, 33155, United States
-
Ep0224 50638
New Brunswick, New Jersey, 08901, United States
-
Ep0224 50639
Orange, California, 92868, United States
-
Ep0224 50640
Winston-Salem, North Carolina, 27157, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.